SCHEMBL13788446

SCHEMBL13788446

Bc1cc(-c2ncccn2)c(N)c([N+](=O)[O-])c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ GALR2 O43603 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MPI P34949 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ CTSB P07858 2/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ TDO2 P48775 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1359386 0.83 ALDH1A1 (0.43) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL13708975 0.72 ALDH1A1 (0.35) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL2910153 0.72 MAPT (0.39) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL1359969 0.72 ALDH1A1 (0.35) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL13788440 0.71 TRPV1 (0.36) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL13468341 0.69 ALDH1A1 (0.43) MAPTALDH1A1NPSR1HTTL3MBTL1
SCHEMBL14549602 0.69 MAPK1 (0.47) MAPTALDH1A1SMN1; SMN2HPGDL3MBTL1
SCHEMBL3834788 0.67 ALDH1A1 (0.57) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL13813006 0.66 CTSB (0.47) MAPTALDH1A1NPSR1HTTSMN1; SMN2
SCHEMBL14538405 0.66 HTT (0.42) MAPTALDH1A1NPSR1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592686-B1 GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2009-07-08 — — EP disclosed
EP-1789419-B1 GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2009-06-17 — — EP disclosed
WO-2007056330-A1 BENZIMIDAZOLE DERIVATIVES AS GYRASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-05-18 — — WO disclosed
Send feedback